bivacard 250mg injection - Bivalirudin (250mg) medicine

Bivastat 250mg Injection (bivalirudin): Comprehensive Medicine Guide

No reviews yet
🏭 Biocon 📦 Varies by brand 💊 Allopathy 📅 Updated: Oct 29, 2026
⚠️ Nephrotoxicity Risk 📋 Prescription Required 💊 Generic Available
Medically Reviewed
11 min read
Evidence: Well-established for approved indications.
Reviewed by
SaathiMed Expert Panel | Oct 29, 2026
🩺
Medically Fact-Checked & Clinically Verified by SaathiMed Clinical Review Board
Clinical Reference Standards: CDSCO (Central Drugs Standard Control Organisation), Indian Pharmacopoeia (IP) & WHO | Last Updated: September 2026

When to Call Your Doctor IMMEDIATELY

  • Severe or uncontrollable bleeding from any site
  • Black, tarry stools or vomiting blood
  • Sudden severe headache, confusion, or vision changes
  • Difficulty breathing, chest pain, or rapid heartbeat
  • Swelling of face, lips, tongue, or throat
  • Decreased urine output or swelling in legs
  • Unusual bruising or petechiae

If experiencing severe symptoms, call emergency services immediately.

What is bivacard 250mg injection used for?

Bivastat 250mg injection contains bivalirudin, a direct thrombin inhibitor used during percutaneous coronary intervention (PCI) and in patients with heparin-induced thrombocytopenia. It is given intravenously by a healthcare professional to prevent blood clots.

  • Generic Name: Bivalirudin
  • Manufacturer: Biocon
  • Form: Allopathy
  • Pregnancy Category: Consult doctor
  • Prescription Required: Yes

🇮🇳 bivacard 250mg injection के बारे में (Hindi Summary)

उपयोग: यह दवा बाइवलिरुडिन 250 मिलीग्राम इंजेक्शन के रूप में उपलब्ध है, जिसका उपयोग अस्पताल में हृदय की कुछ प्रक्रियाओं के दौरान रक्त के थक्के बनने से रोकने के लिए किया जाता है। यह आमतौर पर पर्क्यूटेनियस कोरोनरी इंटरवेंशन (PCI) के दौरान और हेपरिन-प्रेरित थ्रोम्बोसाइटोपेनिया (HIT) वाले रोगियों में दिया जाता है। यह दवा केवल योग्य डॉक्टर या स्वास्थ्यकर्मी द्वारा नस के माध्यम से दी जाती है। इसे घर पर स्वयं न लगाएं।

साइड इफेक्ट्स: आम दुष्प्रभावों में इंजेक्शन स्थल पर रक्तस्राव, हल्की चोट, मतली, सिरदर्द और पीठ दर्द शामिल हैं। गंभीर दुष्प्रभावों में बड़े पैमाने पर रक्तस्राव, गंभीर एलर्जी प्रतिक्रिया और प्लेटलेट्स में कमी हो सकती है। यदि आपको असामान्य रक्तस्राव, काला मल, या गंभीर सिरदर्द हो तो तुरंत डॉक्टर को बताएं।

सुरक्षा सलाह: यह दवा केवल अस्पताल में प्रशिक्षित स्वास्थ्यकर्मी द्वारा दी जानी चाहिए। इसे स्वयं न लगाएं। अपने डॉक्टर को गुर्दे की समस्या, यकृत रोग, हाल ही में हुए रक्तस्राव, या गर्भावस्था के बारे में बताएं। इस दवा को लेते समय चोट लगने वाली गतिविधियों से बचें। डॉक्टर आपके रक्त की जांच और गुर्दे की कार्यप्रणाली की निगरानी करेंगे। बिना डॉक्टर की सलाह के कोई अन्य रक्त पतला करने वाली दवा न लें।

💡 Did You Know? The first generic medicine was introduced in India in 1970 after the Patents Act was amended.

💊 bivacard 250mg injection Uses & Benefits

[{"condition":"Percutaneous coronary intervention (PCI)","description":"Used as an anticoagulant during PCI to prevent thrombus formation in patients with stable angina, unstable angina, or acute myocardial infarction.","evidence":"Well-established"},{"condition":"Heparin-induced thrombocytopenia (HIT)","description":"Used as an alternative anticoagulant in patients with HIT who require parenteral anticoagulation for procedures or treatment.","evidence":"Well-established"},{"condition":"Acute coronary syndromes","description":"May be used in the management of acute coronary syndromes in patients undergoing early invasive strategies.","evidence":"Established"}]

Off-label uses: [{"condition":"Anticoagulation in extracorporeal membrane oxygenation (ECMO)","description":"Sometimes used off-label for anticoagulation in patients on ECMO, though evidence is limited.","evidence":"Limited"},{"condition":"Anticoagulation in pediatric cardiac procedures","description":"Occasionally used off-label in pediatric patients undergoing cardiac catheterization, but dosing is not well established.","evidence":"Limited"}]

Primary treatment for: Percutaneous coronary intervention (PCI)

Also treats: Heparin-induced thrombocytopenia (HIT), Acute coronary syndromes

📋 Drug Information

Generic Name(s)Bivalirudin
Brand NameBivastat 250mg Injection
ManufacturerBiocon
Packaging / FormVaries by brand (Allopathy)
Therapeutic ClassCARDIAC
Action ClassDirect thrombin inhibitor- parenteral
Route of AdministrationIntravenous (IV) only. Administered as a continuous infusion, often with an initial bolus
StorageStore at 2°C to 8°C (36°F to 46°F) in the refrigerator. Do not freeze. Keep in the original carton to protect from light. Once reconstituted, the solution should be used immediately or stored as directed by the manufacturer.
Shelf LifeRefer to the product packaging for the expiration date. Do not use beyond the expiry date.
WHO GuidelineNot established from the available information.
ICMR GuidelineNot established from the available information.

👨‍⚕️ Doctor's Practical Tips

Evidence-based practical advice from experienced clinicians

1
Always verify renal function before initiating bivalirudin, as dose adjustment is required for CrCl <30 mL/min.
2
Monitor aPTT or ACT closely during infusion to ensure therapeutic anticoagulation and avoid excessive bleeding.
3
Have protamine or other reversal agents available, though protamine is not effective for bivalirudin; supportive care is primary.
4
Avoid concomitant use with other anticoagulants unless absolutely necessary, and monitor for bleeding.
5
Educate patients to report any signs of bleeding, such as gum bleeding, nosebleeds, or dark urine, immediately.
6
In patients with HIT, bivalirudin is a preferred anticoagulant due to its lack of cross-reactivity with heparin-induced antibodies.

🔍 Is This Medicine Right for Your Symptom?

Educational reference. Always consult a doctor for diagnosis.

✅
Chest pain during cardiac procedure
This medicine is used to prevent clots during PCI.
Likely Use
✅
Low platelet count due to heparin
This medicine is used in patients with heparin-induced thrombocytopenia.
Likely Use
❌
Fever
This medicine is not a primary fever reducer.
Not Primary

🔬 How This Medicine Works (Pharmacology)

Pharmacokinetics

AbsorptionNot applicable; this medicine is administered intravenously, so absorption is not relevant.
DistributionBivalirudin distributes primarily in the extracellular fluid. It does not bind significantly to plasma proteins other than thrombin. The volume of distribution is approximately 0.2 L/kg.
Protein BindingBivalirudin does not bind to plasma proteins other than thrombin. Plasma protein binding is negligible.
MetabolismBivalirudin is metabolized by proteolytic cleavage, primarily by thrombin itself, and to a lesser extent by other plasma proteases. The metabolites are excreted renally.
Half-LifeThe elimination half-life is approximately 25 minutes in patients with normal renal function. It is prolonged in patients with renal impairment.
ExcretionBivalirudin and its metabolites are primarily excreted by the kidneys. About 20% of the drug is excreted unchanged in urine. Renal clearance is a major determinant of drug elimination.
BioavailabilityNot applicable; this medicine is given intravenously, so bioavailability is 100%.
Onset of ActionAnticoagulant effect occurs immediately after intravenous administration, within minutes.
Peak Plasma TimePeak plasma concentration is achieved immediately after intravenous bolus or at steady state during infusion.
Duration of ActionThe anticoagulant effect lasts for approximately 1 to 2 hours after discontinuation of infusion, depending on renal function.

How It Works

Bivalirudin is a synthetic 20-amino acid peptide that acts as a direct, specific, and reversible inhibitor of thrombin. It binds to both the catalytic site and the anion-binding exosite of thrombin, thereby blocking thrombin-mediated conversion of fibrinogen to fibrin and thrombin-induced platelet activation. Unlike heparin, bivalirudin does not require antithrombin III as a cofactor and is not neutralized by platelet factor 4, making it effective in patients with heparin-induced thrombocytopenia. Its action is concentration-dependent and reversible.

Mechanism Steps

1
Binding to thrombin: Bivalirudin binds directly to thrombin at the catalytic site and the anion-binding exosite.
2
Inhibition of fibrinogen conversion: This binding blocks thrombin from converting fibrinogen to fibrin, preventing clot formation.
3
Inhibition of platelet activation: Bivalirudin also prevents thrombin-mediated activation of platelets, reducing platelet aggregation.
4
Reversible inhibition: The inhibition is reversible, and thrombin activity recovers as bivalirudin is cleared from the bloodstream.

💡 How to Take bivacard 250mg injection

Strength: Sterile lyophilized powder for injection, 250 mg per vial, to be reconstituted and diluted for intravenous infusion.

1This medicine is given by a healthcare professional in a hospital or clinic setting.
2It is administered intravenously, usually as a bolus followed by a continuous infusion.
3You will be monitored for bleeding and other side effects during and after administration.
4Do not attempt to administer this medicine yourself.
5Follow your doctor's instructions regarding other medications and activities.

Dosage Information

Adult DosageThe dose of this medicine is individualized by a qualified clinician based on the indication, patient weight, renal function, and other factors. For percutaneous coronary intervention (PCI), a common regimen is an intravenous bolus of 0.75 mg/kg followed by a continuous infusion of 1.75 mg/kg/hour for the duration of the procedure. For patients with heparin-induced thrombocytopenia, dosing may differ. Dose must be individualized by a qualified clinician based on indication, age, weight, renal and hepatic function.
Pediatric DosagePediatric dosing is not established from available information. Consult a pediatrician.
Elderly DosageElderly patients may have reduced renal function, which can prolong the half-life of bivalirudin. Dose adjustment may be necessary based on creatinine clearance. Monitor closely for bleeding.
Renal ImpairmentIn patients with severe renal impairment (CrCl <30 mL/min), the infusion rate should be reduced. For PCI, a common adjustment is to reduce the infusion rate to 1 mg/kg/hour. For patients on hemodialysis, the dose may need further adjustment. Consult a nephrologist or clinical pharmacist for specific dosing.
Hepatic ImpairmentNo specific dose adjustment is recommended for hepatic impairment. However, monitor liver function and bleeding signs.
Maximum Daily DoseThe maximum daily dose is not fixed and depends on the indication, patient weight, and renal function. It is determined by the prescribing clinician.

Dosage Timeline

🌅 Morning ❌ ☀️ Afternoon ❌ 🌆 Evening ❌ 🌙 Night ❌

🍽️ Food Timing Guide

No specific food interactions
No restrictions
Bivalirudin is given intravenously and does not interact with food.

⏰ What to Do If You Miss a Dose

📌 If a dose is missed during hospital infusion
→ Inform the healthcare provider immediately.
💡 Do not attempt to adjust the infusion yourself.

⚠️ Side Effects of bivacard 250mg injection

✅ Common Side Effects

Bleeding from injection site (Common (≥1%))
Apply pressure to the site. Inform your nurse or doctor if bleeding persists.
Nausea (Common (≥1%))
Usually resolves on its own. Inform your doctor if it becomes bothersome.
Headache (Common (≥1%))
Rest and stay hydrated. Consult your doctor if severe or persistent.
Back pain (Common (≥1%))
Report to your doctor if it interferes with daily activities.

🚨 Serious Side Effects

Major bleeding (e.g., gastrointestinal, intracranial) (Uncommon (0.1-1%))
Seek immediate medical attention if you notice signs of bleeding such as black stools, vomiting blood, severe headache, or confusion.
Severe allergic reaction (anaphylaxis) (Rare (<0.1%))
Get emergency help immediately if you experience swelling of face, lips, throat, difficulty breathing, or rash.
Thrombocytopenia (Uncommon (0.1-1%))
Your doctor will monitor platelet counts. Report any unusual bruising or bleeding.

⚠️ Rare Side Effects

Retroperitoneal bleeding
Seek immediate medical attention if you experience severe abdominal or back pain, or signs of shock.
Hemopericardium
Report chest pain, shortness of breath, or palpitations immediately.
Pulmonary hemorrhage
Seek emergency care if you cough up blood or have difficulty breathing.

Consult your doctor if you experience any unusual symptoms.

🔬 Drug Interactions

Drug Severity Effect
Warfarin Major
DOACs Major
Thrombolytics Major
GP IIb/IIIa inhibitors Major
NSAIDs Moderate
SSRIs/SNRIs Moderate
Corticosteroids Moderate
Antiplatelet agents Minor
Herbal supplements (ginkgo, garlic) Minor
Alcohol Moderate

🚨 Major Interactions

  • Warfarin
  • Direct oral anticoagulants (DOACs)
  • Thrombolytic agents (e.g., alteplase)
  • Glycoprotein IIb/IIIa inhibitors (e.g., abciximab)

⚡ Moderate Interactions

  • NSAIDs (e.g., ibuprofen, naproxen)
  • SSRIs/SNRIs
  • Corticosteroids

🍷 Alcohol Interaction

Alcohol may increase the risk of gastrointestinal bleeding and should be avoided while receiving this medicine. Consult your doctor for personalized advice.

🔎 Check Your Other Medicines

Educational tool. Always confirm with your doctor or pharmacist.

🛡️ Safety & Warnings

🚫 Contraindications

["Active major bleeding","Severe uncontrolled hypertension","Known hypersensitivity to bivalirudin or any component of the formulation","Severe renal impairment (CrCl

⚠️ Warnings & Precautions

["Bleeding risk: Bivalirudin increases the risk of bleeding. Monitor closely, especially in patients with renal impairment or those receiving other anticoagulants.","Renal impairment: Dose reduction is required for patients with CrCl

🤱 Lactation Safety

It is not known whether bivalirudin is excreted in human breast milk. Because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.

💊 Overdose Management

There is no specific antidote for bivalirudin overdose. In case of overdose, discontinue the infusion immediately and monitor the patient closely for signs of bleeding. Supportive care should be provided. Bivalirudin is dialyzable; hemodialysis may be considered in severe cases with renal impairment. Contact a poison control center or emergency services immediately.

⏰ Missed Dose

This medicine is administered by a healthcare professional in a controlled setting. If you miss a scheduled dose, inform your healthcare provider immediately. Do not attempt to self-administer or double the dose.

Additional Safety Advice

General Safety

This medicine must be administered only by a healthcare professional in a hospital or clinic equipped to monitor and manage bleeding complications. Do not attempt to self-administer. Inform your doctor if you have kidney problems, liver disease, recent bleeding, or are pregnant or breastfeeding. Avoid activities that increase bleeding risk, such as contact sports or using sharp objects, while receiving this medicine. Your doctor will monitor your blood counts, kidney function, and signs of bleeding during treatment. Do not take any other blood-thinning medicines without consulting your doctor. If you miss a dose, inform your healthcare provider immediately; do not try to catch up on your own.

👴 Special Considerations for Elderly

💡 For Patients Above 65

Elderly patients are more likely to have reduced renal function, which can prolong the half-life of bivalirudin and increase bleeding risk. Dose adjustment based on creatinine clearance is essential. Monitor closely for bleeding and renal function.

🤰 Pregnancy Planning (TTC)

If you are planning pregnancy, consult your doctor before receiving this medicine. Bivalirudin is Pregnancy Category B, but use only if clearly needed. Discuss risks and benefits with your healthcare provider.

🏥 Post-Surgery Considerations

After surgery, bivalirudin may be used to prevent clots, but bleeding risk must be balanced. Monitor surgical site for bleeding and follow your surgeon's instructions.

🦷 Dental Procedures

Inform your dentist if you are receiving or have recently received bivalirudin, as it increases bleeding risk. Dental procedures may need to be postponed or managed with caution.

💚 Lifestyle Tips for Better Results

🏃
Avoid activities that increase bleeding risk, such as contact sports, while receiving this medicine.
🥗
Inform your doctor about all medications and supplements you take.
😴
Stay hydrated unless otherwise instructed.
💧
Follow a heart-healthy diet to support cardiovascular health.
🧘
Attend all follow-up appointments for monitoring.
🌞
Do not smoke, as it increases cardiovascular risk.

🏋️ Exercise Considerations

Avoid strenuous exercise or activities that could cause injury while on this medicine, as bleeding risk is increased. Light activity is generally safe, but consult your doctor before starting any exercise program.

🥗 Diet Recommendations

Follow a balanced diet rich in fruits, vegetables, and whole grains.
Limit foods high in saturated fats and trans fats.
Reduce sodium intake to manage blood pressure.
Avoid alcohol, as it increases bleeding risk.
Stay well hydrated unless fluid restriction is advised.

💼 Impact on Daily Work & Life

This medicine is given in a hospital setting, so it may require a short hospital stay. After discharge, you may need to avoid driving or operating heavy machinery if you feel dizzy or weak. Follow your doctor's advice regarding return to work.

🛑 When to Stop This Medicine

Do not stop this medicine without consulting your doctor. It is usually stopped by the healthcare provider after the procedure or when anticoagulation is no longer needed. If you experience severe bleeding or allergic reactions, seek immediate medical attention.

📅 Long-Term Use Effects

Bivalirudin is typically used for short durations during procedures or acute care. Long-term effects are not well studied because it is not intended for chronic use. Prolonged use may increase bleeding risk and require monitoring of renal function and platelet counts. When used in HIT, it is continued until alternative anticoagulation is established.

🌿 Non-Medicine Approaches

These can complement medicine but do not replace prescribed treatment.

Heparin

Alternative anticoagulant, but contraindicated in HIT.

Evidence: Well-established
Argatroban

Another direct thrombin inhibitor used in HIT.

Evidence: Well-established
Fondaparinux

Factor Xa inhibitor, but not recommended for PCI due to lack of efficacy data.

Evidence: Limited

💉 Vaccination Considerations

💉 If You're Getting Vaccinated

No specific vaccine interactions are known. However, inform your doctor about your vaccination status and any recent vaccinations.

📦 Storage Guide

✅ DO

Store in refrigerator at 2°C to 8°C

❌ DON'T

Do not freeze

✅ DO

Keep in original carton to protect from light

❌ DON'T

Do not use if solution is discolored or contains particles

✅ DO

Use reconstituted solution immediately as directed

❌ DON'T

Do not store reconstituted solution for extended periods unless specified

✈️ Traveling with This Medicine

This medicine is administered in a hospital setting and is not for self-administration during travel. If you are traveling after treatment, carry a copy of your prescription and medical records. Inform your doctor before travel, especially if you have renal impairment. Store the medicine as directed if you are carrying it, but it is unlikely to be needed outside a medical facility.

💰 Cost Analysis & Savings

👥 Real Patient Stories

Educational, anonymized scenarios. Individual results may vary.

👤 A 62-year-old man with unstable angina undergoing PCI
He received bivalirudin during the procedure. His clotting times were monitored closely, and the procedure was successful without bleeding complications. He was advised to avoid alcohol and NSAIDs post-procedure.
💡 Lesson: Close monitoring during bivalirudin infusion helps prevent bleeding and ensures procedural success.
👤 A 55-year-old woman with heparin-induced thrombocytopenia
She was started on bivalirudin for anticoagulation due to HIT. Her platelet counts improved, and she did not experience any bleeding events. She was educated about the importance of follow-up blood tests.
💡 Lesson: Bivalirudin is an effective alternative for patients with HIT, but regular monitoring is essential.

💬 Questions Patients Often Ask

Q: How long does it take to work?

A: This medicine starts working immediately after intravenous administration, within minutes.

Q: How is this medicine given?

A: It is given intravenously by a healthcare professional, usually as a bolus followed by a continuous infusion.

Q: What are the common side effects?

A: Common side effects include bleeding from the injection site, nausea, headache, and back pain.

Q: Is this medicine safe in pregnancy?

A: It is Pregnancy Category B. Use only if clearly needed, as determined by your doctor.

Q: Can I take this medicine at home?

A: No, this medicine must be administered by a healthcare professional in a hospital or clinic setting.

🤔 Common Patient Concerns

💭 These are the concerns patients most commonly raise

  • Can I take this medicine if I have kidney disease?
  • Will this medicine affect my platelet count?
  • Can I drive after receiving this medicine?
  • Does this medicine interact with my blood pressure medicines?
  • What if I miss a dose?
  • Can I drink alcohol while on this medicine?

🔄 Substitutes for bivacard 250mg injection

View All

Alternative brands with exact same active ingredient:

Medical Note: Always consult your doctor before switching medications.

🛑 Myths vs. Facts

  • Myth: Bivastat 250mg injection can be self-administered at home.
    Fact: This medicine must be given by a healthcare professional in a hospital setting.
  • Myth: Bivastat 250mg injection is the same as heparin.
    Fact: Bivalirudin is a direct thrombin inhibitor, while heparin works via antithrombin III. They have different mechanisms and uses.
  • Myth: Bivastat 250mg injection has no bleeding risk.
    Fact: Like all anticoagulants, bivalirudin increases the risk of bleeding, and patients must be monitored closely.

🔄 Alternative Options

Generic Alternatives

  • Bivalirudin

Brand Alternatives

  • Angiomax

📊 Comparison with Similar Medicines

[{"medicine":"Bivalirudin","class":"Direct thrombin inhibitor","route":"Intravenous","half_life":"~25 minutes","renal_adjustment":"Yes"},{"medicine":"Heparin","class":"Indirect thrombin inhibitor","route":"Intravenous/Subcutaneous","half_life":"1-2 hours","renal_adjustment":"No"},{"medicine":"Argatroban","class":"Direct thrombin inhibitor","route":"Intravenous","half_life":"40-50 minutes","renal_adjustment":"No (hepatic adjustment)"}]

😊 Was this information helpful?

Browse Medicines A-Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Back to Medicines Directory